Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives

Non-Hodgkin lymphoma (NHL) is a heterogeneous malignancy with variable patient outcomes. There is still a lack of understanding about the different players involved in lymphomagenesis, and the identification of new diagnostic and prognostic biomarkers is urgent. MicroRNAs and long non-coding RNAs em...

Full description

Saved in:
Bibliographic Details
Published inBiomedicines Vol. 9; no. 12; p. 1934
Main Authors Fernandes, Mara, Marques, Herlander, Teixeira, Ana Luísa, Medeiros, Rui
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 17.12.2021
MDPI
Subjects
B-cell lymphoma
Biomarkers
Biopsy
Cell cycle
Cell growth
Chemotherapy
Gene expression
lncRNAs
Lymphocytes B
Lymphoma
Malignancy
Medical prognosis
MicroRNAs
miRNA
miRNAs
Molecular modelling
Non-coding RNA
Non-Hodgkin's lymphoma
Pathogenesis
Patients
Review
Transcription factors
lncRNAs
non-Hodgkin’s lymphoma
miRNAs
biomarkers
lymphoma
Online AccessGet full text

Cover

More Information
Summary:Non-Hodgkin lymphoma (NHL) is a heterogeneous malignancy with variable patient outcomes. There is still a lack of understanding about the different players involved in lymphomagenesis, and the identification of new diagnostic and prognostic biomarkers is urgent. MicroRNAs and long non-coding RNAs emerged as master regulators of B-cell development, and their deregulation has been associated with the initiation and progression of lymphomagenesis. They can function by acting alone or, as recently proposed, by creating competing endogenous RNA (ceRNA) networks. Most studies have focused on individual miRNAs/lncRNAs function in lymphoma, and there is still limited data regarding their interactions in lymphoma progression. The study of miRNAs' and lncRNAs' deregulation in NHL, either alone or as ceRNAs networks, offers new insights into the molecular mechanisms underlying lymphoma pathogenesis and opens a window of opportunity to identify potential diagnostic and prognostic biomarkers. In this review, we summarized the current knowledge regarding the role of miRNAs and lncRNAs in B-cell lymphoma, including their interactions and regulatory networks. Finally, we summarized the studies investigating the potential of miRNAs and lncRNAs as clinical biomarkers, with a special focus on the circulating profiles, to be applied as a non-invasive, easy-to-obtain, and reproducible liquid biopsy for dynamic management of NHL patients.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2227-9059
2227-9059
DOI:10.3390/biomedicines9121934